I'm concerned about all the projects, including the AP. The vast majority are with industry partners who stand to make a huge, continuing profit from their products -- which means that a real cure would kill them business-wise. This is a massive conflict of interest and industry partners seem to be driving the direction of the research -- the CEOs of companies who have funded projects (with parent-raised money) sit on the JDRF board. Lewis, the CEO, is from Novocell and the chairman of the board from J&J. Even if you have a kid with T1, it's still hard to separate your corporate interests from research that should only have the best interests of type 1's at heart, not huge multi-nationals' bottom lines. This has become true of nearly all areas of medical research, not just diabetes. That's why we're not seeing anything come out but more expensive drugs and treatments that you get stuck using to stay alive. I hate to see the foundations and the corporations goals and missions getting tanged up in this gray area. They should be separate, because of the potential conflict. At least the AP might give something to our kids and I love the pump and CGM. I'd rather not subsidize industry, though. They are already making such huge profits that the percentage of our income spent on healthcare keeps going up every year.